Artificial intelligence is rapidly transforming pharmaceutical R&D, from target identification to molecule design and clinical prediction. For foreign investors building AI-driven drug discovery platforms, Turkey can be both a development hub and a strategic IP jurisdiction – but only if you structure patent and software protection correctly under Turkish law. This overview explains how AI-based […]